Results 101 to 110 of about 1,091,366 (233)

Topical TYK2 inhibitor ameliorates psoriasis‐like dermatitis via the AKT‐SP1‐NGFR‐AP1 pathway in keratinocytes

open access: yesClinical and Translational Medicine
Introduction Tyrosine kinase 2 (TYK2)‐dependent cytokine signalling is integral to the pathogenesis of psoriasis. While BMS‐986165, a highly selective TYK2 inhibitor, has recently been approved for oral treatment of psoriasis, its therapeutic potential ...
Zhiqin Fang   +5 more
doaj   +1 more source

The Mortality from Cancer of the Skin and Lip in Certain Occupations [PDF]

open access: bronze, 1949
M Atkin   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy